130 related articles for article (PubMed ID: 8824565)
1. Mutation of p53 gene in hepatocellular carcinoma cell lines with HBX DNA.
Kang MS; Lee HJ; Lee JH; Ku JL; Lee KP; Kelley MJ; Won YJ; Kim ST; Park JG
Int J Cancer; 1996 Sep; 67(6):898-902. PubMed ID: 8824565
[TBL] [Abstract][Full Text] [Related]
2. [Polymorphism of hepatitis B virus x gene in hepatocellular carcinoma patients and the biological effects of HBx gene with deletion varations on QSG7701 cells].
Zhu PA; Tan DM; Peng ZT; Liu F; Song L
Zhonghua Gan Zang Bing Za Zhi; 2008 Jan; 16(1):7-11. PubMed ID: 18226335
[TBL] [Abstract][Full Text] [Related]
3. Polymorphism analyses of hepatitis B virus X gene in hepatocellular carcinoma patients from southern China.
Zhu P; Tan D; Peng Z; Liu F; Song L
Acta Biochim Biophys Sin (Shanghai); 2007 Apr; 39(4):265-72. PubMed ID: 17417681
[TBL] [Abstract][Full Text] [Related]
4. [Relationship between mutation on precore region of integrated HBV DNA and p53 gene mutation in hepatocellular carcinoma].
Wang XH; Wang PL
Ai Zheng; 2003 Jul; 22(7):715-8. PubMed ID: 12866962
[TBL] [Abstract][Full Text] [Related]
5. Identification of hepatitis B virus X gene mutation in Hong Kong patients with hepatocellular carcinoma.
Chen GG; Li MY; Ho RL; Chak EC; Lau WY; Lai PB
J Clin Virol; 2005 Sep; 34(1):7-12. PubMed ID: 16087118
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of hepatitis-B-virus core promoter by p53: implications for carcinogenesis in hepatocytes.
Uchida T; Takahashi K; Tatsuno K; Dhingra U; Eliason JF
Int J Cancer; 1996 Sep; 67(6):892-7. PubMed ID: 8824564
[TBL] [Abstract][Full Text] [Related]
7. COOH-terminal deletion of HBx gene is a frequent event in HBV-associated hepatocellular carcinoma.
Liu XH; Lin J; Zhang SH; Zhang SM; Feitelson MA; Gao HJ; Zhu MH
World J Gastroenterol; 2008 Mar; 14(9):1346-52. PubMed ID: 18322946
[TBL] [Abstract][Full Text] [Related]
8. TP53 R249S mutation, genetic variations in HBX and risk of hepatocellular carcinoma in The Gambia.
Gouas DA; Villar S; Ortiz-Cuaran S; Legros P; Ferro G; Kirk GD; Lesi OA; Mendy M; Bah E; Friesen MD; Groopman J; Chemin I; Hainaut P
Carcinogenesis; 2012 Jun; 33(6):1219-24. PubMed ID: 22759751
[TBL] [Abstract][Full Text] [Related]
9. p53 gene mutation and integrated hepatitis B viral DNA sequences in human liver cancer cell lines.
Hsu IC; Tokiwa T; Bennett W; Metcalf RA; Welsh JA; Sun T; Harris CC
Carcinogenesis; 1993 May; 14(5):987-92. PubMed ID: 8389256
[TBL] [Abstract][Full Text] [Related]
10. Analysis of the tumorigenicity of the X gene of hepatitis B virus in a nontransformed hepatocyte cell line and the effects of cotransfection with a murine p53 mutant equivalent to human codon 249.
Oguey D; Dumenco LL; Pierce RH; Fausto N
Hepatology; 1996 Nov; 24(5):1024-33. PubMed ID: 8903370
[TBL] [Abstract][Full Text] [Related]
11. [The relation between p53 mutations and tumor invasiveness of human hepatocellular carcinoma].
Qin L; Tang Z; Liu K
Zhonghua Zhong Liu Za Zhi; 1995 Nov; 17(6):405-8. PubMed ID: 8697987
[TBL] [Abstract][Full Text] [Related]
12. Differentially expressed genes associated with hepatitis B virus HBx and MHBs protein function in hepatocellular carcinoma.
Kim DG
Methods Mol Biol; 2006; 317():141-55. PubMed ID: 16264227
[TBL] [Abstract][Full Text] [Related]
13. Expression of integrated hepatitis B virus X variants in human hepatocellular carcinomas and its significance.
Chen WN; Oon CJ; Leong AL; Koh S; Teng SW
Biochem Biophys Res Commun; 2000 Oct; 276(3):885-92. PubMed ID: 11027564
[TBL] [Abstract][Full Text] [Related]
14. [Detection of p53 gene mutations in hepatocellular carcinoma].
Zhou F; Wang J; Lei B; Zhao L; Tang H; Wang X; Zhang X; Li F
Hua Xi Yi Ke Da Xue Xue Bao; 1997 Mar; 28(1):50-4. PubMed ID: 10684062
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis B virus X protein mutant upregulates CENP-A expression in hepatoma cells.
Liu L; Li Y; Zhang S; Yu D; Zhu M
Oncol Rep; 2012 Jan; 27(1):168-73. PubMed ID: 21956590
[TBL] [Abstract][Full Text] [Related]
16. [Study on p53 gene mutation in hepatocellular carcinoma patients in China].
Kang G; Fang Z; Volkmann M
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2001 Jun; 15(2):163-5. PubMed ID: 11436649
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of DNMT1 mediated by HBx suppresses RASSF1A expression independent of DNA methylation.
Qiu X; Zhang L; Lu S; Song Y; Lao Y; Hu J; Fan H
Oncol Rep; 2014 Jan; 31(1):202-8. PubMed ID: 24247422
[TBL] [Abstract][Full Text] [Related]
18. The role of previous infection of hepatitis B virus in Hbs antigen negative and anti-HCV negative Japanese patients with hepatocellular carcinoma: etiological and molecular biological study.
Matsuzaki Y; Sato M; Saito Y; Karube M; Doy M; Shoda J; Abei M; Tanaka N; Hadama T; Kinoshita M
J Exp Clin Cancer Res; 1999 Sep; 18(3):379-89. PubMed ID: 10606185
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis B virus X mutants, present in hepatocellular carcinoma tissue abrogate both the antiproliferative and transactivation effects of HBx.
Sirma H; Giannini C; Poussin K; Paterlini P; Kremsdorf D; Bréchot C
Oncogene; 1999 Aug; 18(34):4848-59. PubMed ID: 10490818
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis B, aflatoxin B(1), and p53 codon 249 mutation in hepatocellular carcinomas from Guangxi, People's Republic of China, and a meta-analysis of existing studies.
Stern MC; Umbach DM; Yu MC; London SJ; Zhang ZQ; Taylor JA
Cancer Epidemiol Biomarkers Prev; 2001 Jun; 10(6):617-25. PubMed ID: 11401911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]